Korro Bio

Cambridge, United States

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

$85.0M raised

Mar 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Korro Bio raised?

Korro Bio has raised $85.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.

Who are Korro Bio's investors?

Korro Bio's investors include New Enterprise Associates, Balyasny Asset Management, Blue Owl, Point72, Cormorant Asset Management.

Where is Korro Bio headquartered?

Korro Bio is headquartered in Cambridge, United States.

What does Korro Bio do?

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

What stage is Korro Bio at?

Korro Bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 9, 2026.

MLA

"Korro Bio — Funding & Investors." VCBacked, March 9, 2026, https://www.vcbacked.co/company/korro-bio. Accessed July 2, 2026.

APA

VCBacked. (2026). Korro Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/korro-bio

Wikipedia (cite web)

{{cite web |title=Korro Bio — Funding & Investors |url=https://www.vcbacked.co/company/korro-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 9, 2026.